OMEPRAZOLE DR
- Product NDC
- 61919-773
- 11-digit product format
- 619190773
- Labeler code
- 61919
- Product ID
- 61919-773_c1c31f1c-23b7-6193-e053-2995a90abc73
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OMEPRAZOLE DR
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA076048
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- OMEPRAZOLE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-773-30 | OMEPRAZOLE DR | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| OMEPRAZOLE | ACTIVE INGREDIENT | KG60484QX9 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| OMEPRAZOLE | ACTIVE MOIETY | KG60484QX9 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| MAGNESIUM HYDROXIDE | INACTIVE INGREDIENT | NBZ3QY004S | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE [DIRECT RX] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-773 | OMEPRAZOLE DR CAPSULE, DELAYED RELEASE OMEPRAZOLE CAPSULE, DELAYED RELEASE [DIRECT RX] | 14 | Legacy NDC, 1 package rows | 20230602_c6bc8fb7-2862-464a-b7c9-e409034f072a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-773-30 | 61919077330 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (61919-773-30) | 2017-01-01 | 0000-00-00 | No | No | Current |